A common diabetes and weight-loss drug can reduce symptoms of depression through an unexpected route: by altering the gut microbiome rather than acting directly on the brain. Researchers at Southeast University in Jiangsu, China, led by co-corresponding author Yonggui Yuan, studied the GLP-1 receptor agonist liraglutide (marketed as Victoza and Saxenda) in male mice exposed to chronic stress. They found that the drug accumulates primarily in the intestine, not in the brain, and triggers a surge in the beneficial bacterium Lactobacillus delbrueckii.
Key Findings
In a series of experiments published June 10, 2026, in Cell Host & Microbe, the researchers demonstrated that liraglutide’s antidepressant and anti-anxiety effects persist even in mice genetically engineered to lack GLP-1 receptors in the brain. This suggests the drug works independently of its known brain targets. When the team wiped out the mice’s gut bacteria with broad-spectrum antibiotics, the mood benefits disappeared completely. Fecal metagenomic sequencing identified L. delbrueckii as the single most increased microbe after liraglutide treatment, and its abundance correlated with the degree of behavioral improvement.
Further analysis showed that this bacterium produces large amounts of diacylglycerol, a precursor that the mouse body converts into 2-arachidonoylglycerol (2-AG), a naturally occurring endocannabinoid. Elevated 2-AG levels calm hyperactive stress circuits in the brain, reducing depressive behaviors.
Why It Matters for Your Brain
This study challenges the long-held assumption that GLP-1 drugs improve mood by crossing the blood-brain barrier and stimulating neural receptors. Instead, the gut microbiome appears to be the main mediator. For the millions taking GLP-1 agonists like liraglutide or semaglutide (Ozempic, Wegovy), these findings suggest that any mental health benefits—or possible mood changes—may depend on the health of their gut ecosystem. It also hints at a future where targeted probiotics, specifically L. delbrueckii strains, could be used to support mental health in people with obesity or type 2 diabetes, without relying solely on drugs.
What You Can Do
While you can’t buy a specific probiotic based on this single study, you can support your gut microbiome and, potentially, your mood with a fiber-rich diet, fermented foods (yogurt, kefir, sauerkraut), and regular exercise. If you’re taking a GLP-1 drug, talk to your doctor about monitoring mood changes and consider adding probiotic foods. The study notes that only male mice were used, so future research must confirm these effects in females and humans.
Source: Neuroscience News
Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.
